Las Vegas Sun

Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and ...

AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...
MobiHealthNews

Springbok Analytics receives FDA 510(k) clearance for MuscleView

Springbok Analytics, a life sciences muscle and analytics company, has received FDA 510(k) clearance for MuscleView, an AI-powered technology that analyzes muscle health via magnetic resonance (MR) ...
Monthly Prescribing Reference

FDA Approves Lower-Dose Gadolinium Contrast Agent Ambelvist

Credit: Bayer. Two phase 3 trials supported the approval of gadoquatrane, a novel macrocyclic GBCA for imaging CNS and non-CNS pathologies. The novel macrocyclic contrast agent delivers high-quality ...

Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026

MALMÖ, SE / ACCESS Newswire / June 9, 2026 / Ascelia Pharma AB (publ)(STO:ACE) announces that Orviglance® data will be presented as an oral presentation today at the European Society of ...